Perrigo Company plc Increase (Decrease) in Deferred Income Taxes
Perrigo Company plc (PRGO) reported Increase (Decrease) in Deferred Income Taxes of $90.20 million for the 9-month period ending 2015-03-28, per its 10-Q filed 2015-04-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2015-04-29
- Perrigo Company plc increase (decrease) in deferred income taxes for the quarter ending 2015-03-28 was $0.00.
- Perrigo Company plc increase (decrease) in deferred income taxes for the quarter ending 2014-12-27 was $0.00.
- Perrigo Company plc increase (decrease) in deferred income taxes for the quarter ending 2014-09-27 was $90.20M.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 9 month |
|---|---|---|---|
| 2015-03-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | $0.00 derived: sum of 2 quarters · filed 2015-04-29 | $90.20M 10-Q · filed 2015-04-29 |
| 2014-12-27 | $0.00 derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05 | $90.20M 10-Q · filed 2015-02-05 | |
| 2014-09-27 | $90.20M 8-K · filed 2014-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |